Our top pick for
AutoWeb Inc is an internet content & information business based in the US. AutoWeb shares (AUTO) are listed on the NASDAQ and all prices are listed in US Dollars. AutoWeb employs 149 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$3.19|
|52-week range||$2.15 - $3.95|
|50-day moving average||$2.74|
|200-day moving average||$2.80|
|Wall St. target price||$4.75|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.11|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-19)||6.33%|
|1 month (2021-09-24)||21.29%|
|3 months (2021-07-26)||6.33%|
|6 months (2021-04-26)||21.29%|
|1 year (2020-10-26)||-13.08%|
|2 years (2019-10-25)||21.99%|
|3 years (2018-10-26)||38.70%|
|5 years (2016-10-26)||16.25|
Valuing AutoWeb stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of AutoWeb's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
AutoWeb's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $421,000.
The EBITDA is a measure of a AutoWeb's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$71.7 million|
|Gross profit TTM||$23.7 million|
|Return on assets TTM||-3.44%|
|Return on equity TTM||-8.08%|
|Market capitalisation||$43 million|
TTM: trailing 12 months
There are currently 185,812 AutoWeb shares held short by investors – that's known as AutoWeb's "short interest". This figure is 5.1% up from 176,805 last month.
There are a few different ways that this level of interest in shorting AutoWeb shares can be evaluated.
AutoWeb's "short interest ratio" (SIR) is the quantity of AutoWeb shares currently shorted divided by the average quantity of AutoWeb shares traded daily (recently around 67814.598540146). AutoWeb's SIR currently stands at 2.74. In other words for every 100,000 AutoWeb shares traded daily on the market, roughly 2740 shares are currently held short.
However AutoWeb's short interest can also be evaluated against the total number of AutoWeb shares, or, against the total number of tradable AutoWeb shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AutoWeb's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 AutoWeb shares in existence, roughly 10 shares are currently held short) or 0.0207% of the tradable shares (for every 100,000 tradable AutoWeb shares, roughly 21 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against AutoWeb.
Find out more about how you can short AutoWeb stock.
We're not expecting AutoWeb to pay a dividend over the next 12 months.
AutoWeb's shares were split on a 1:5 basis on 11 July 2012. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your AutoWeb shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for AutoWeb shares which in turn could have impacted AutoWeb's share price.
Over the last 12 months, AutoWeb's shares have ranged in value from as little as $2.15 up to $3.95. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AutoWeb's is 2.1683. This would suggest that AutoWeb's shares are significantly more volatile than the average for this exchange and represent a higher risk.
AutoWeb, Inc. operates as a digital marketing company for the automotive industry in the United States. It assists automotive retail dealers and manufacturers to market and sell new and used vehicles to consumers through its programs. The company's products include new vehicle lead program, which allows consumers to submit requests for pricing and availability of specific makes and models; and used vehicle lead program, which allows consumers to search for used vehicles according to specific search parameters, such as price, make, model, mileage, year, and location of the vehicle. Its products and services also comprise WebLeads+ that offers various coupon options, which display marketing messages to consumers visiting the dealer's Website; and Payment Pro, a dealer website conversion tool that offers consumers real-time online monthly payment information, as well as sells fixed placement advertising across its Website to automotive advertisers. The company owns and operates automotive websites that offers consumers with the information and tools to aid them with their automotive purchase decisions; direct marketing platform that enables manufacturers to selectively target in-market consumers during the often-extended vehicle shopping process; and click traffic referral program, a pay-per-click advertising program that offer targeted offers to consumers based on make, model, and geographic location. The company was formerly known as Autobytel Inc.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.